TriSalus Life Sciences (TLSI) Cash & Equivalents Growth (3y) (2023 - 2026)

TriSalus Life Sciences (TLSI) Cash & Equivalents Growth (3y) (2023 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash & Equiv. Growth (3y) (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	-13.31%
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	34.27%
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	8.10%
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	8.16%
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	40.74%
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	-2.57%
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	2.72%
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	38.28%
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	32.23%
10	TriSalus Life Sciences	306.06 Mn	259.77 Mn	9.90 Mn	663.57%

Download Data